Singapore - English - HSA (Health Sciences Authority)

spacelabs healthcare pte. ltd. - general hospital - the heartsave is designed for use in automatic mode by suitably qualified first-aiders, trained paramedics and doctors in their everyday clinical activities, either within a hospital or in the preclinical area of emergency medicine. only doctors are authorised to use the device in manual mode. it may only be used on patients who are unconscious and who are not breathing. the device is used to carry out transthoracic defibrillations. the main application is defibrillation in asynchronous manual mode; an additional application is the cardioversion for atrial fibrillation in synchronous manual mode. the primedic™ heartsave defibrillators may only be used for defibrillation if the patient is unconscious, not breathing, or a child over 8 years of age or having a minimum body weight of 25 kg.

India - English - Central Drugs Standard Control Organization

shreya - diclofenac sod.,serratiopeptidase - tab - 50,10;mg - 10

Ireland - English - HPRA (Health Products Regulatory Authority)

murphy healthcare ireland ltd., - paracetamol - tablets - 500 milligram

India - English - Central Drugs Standard Control Organization

shreya - serratiopeptidase - tab - 10mg - 10

India - English - Central Drugs Standard Control Organization

shreya - serratiopeptidase - tab - 5mg - 10

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - mebendazole -

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (unii: f4tn0ipy37) (bordetella pertussis toxoid antigen (glutaraldehyde inactivated) - unii:f4tn0ipy37 - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) 15 [lf] in 0.5 ml - daptacel® is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age (prior to seventh birthday). a severe allergic reaction (e.g., anaphylaxis) after a previous dose of daptacel or any other tetanus toxoid, diphtheria toxoid, or pertussis-containing vaccine, or any other component of this vaccine is a contraindication to administration of daptacel. [see description (11). ] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of a previous dose of a pertussis containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis-containing vaccine, inclu

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - ciclesonide (unii: s59502j185) (ciclesonide - unii:s59502j185) - ciclesonide 50 ug - omnaris nasal spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. omnaris nasal spray is indicated for the treatment of nasal symptoms associated with perennial allergic rhinitis in adults and adolescents 12 years of age and older. omnaris nasal spray is contraindicated in patients with a hypersensitivity to any of its ingredients.

United States - English - NLM (National Library of Medicine)

jacksonville pharmaceuticals, inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 400 ug - nitroglycerin lingual spray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. do not use nitroglycerin lingual spray in patients who are taking pde-5-inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil. concomitant use can cause severe hypotension, syncope, or myocardial ischemia [see drug interactions (7.1) ]. do not use nitroglycerin lingual spray in patients who are taking soluble guanylate cyclase (sgc) stimulators, such as riociguat. concomitant use can cause hypotension. nitroglycerin lingual spray is contraindicated in patients with severe anemia (large doses of nitroglycerin may cause oxidation of hemoglobin to methemoglobin and could exacerbate anemia). nitroglycerin lingual spray  may precipitate or aggravate increased intracranial pressure and thus should not be used in patients with possible increased intracranial pressure (e. g. cerebral hemorrhage or traumatic brain injury). nitroglycerin lingual spray is c

United States - English - NLM (National Library of Medicine)

novadel pharma inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - aerosol, spray - 400 ug - nitromist is indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. administration of nitromist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cgmp)-specific phosphodiesterase type 5 (pde5), as pde5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates [see drug interactions 7.1 )]. nitromist is contraindicated in patients with severe anemia. nitromist is contraindicated in patients with increased intracranial pressure nitromist is contraindicated in patients who have shown hypersensitivit